» Articles » PMID: 39659701

AI and ML-based Risk Assessment of Chemicals: Predicting Carcinogenic Risk from Chemical-induced Genomic Instability

Overview
Journal Front Toxicol
Date 2024 Dec 11
PMID 39659701
Authors
Affiliations
Soon will be listed here.
Abstract

Chemical risk assessment plays a pivotal role in safeguarding public health and environmental safety by evaluating the potential hazards and risks associated with chemical exposures. In recent years, the convergence of artificial intelligence (AI), machine learning (ML), and omics technologies has revolutionized the field of chemical risk assessment, offering new insights into toxicity mechanisms, predictive modeling, and risk management strategies. This perspective review explores the synergistic potential of AI/ML and omics in deciphering clastogen-induced genomic instability for carcinogenic risk prediction. We provide an overview of key findings, challenges, and opportunities in integrating AI/ML and omics technologies for chemical risk assessment, highlighting successful applications and case studies across diverse sectors. From predicting genotoxicity and mutagenicity to elucidating molecular pathways underlying carcinogenesis, integrative approaches offer a comprehensive framework for understanding chemical exposures and mitigating associated health risks. Future perspectives for advancing chemical risk assessment and cancer prevention through data integration, advanced machine learning techniques, translational research, and policy implementation are discussed. By implementing the predictive capabilities of AI/ML and omics technologies, researchers and policymakers can enhance public health protection, inform regulatory decisions, and promote sustainable development for a healthier future.

References
1.
Sille F, Karakitsios S, Kleensang A, Koehler K, Maertens A, Miller G . The exposome - a new approach for risk assessment. ALTEX. 2020; 37(1):3-23. DOI: 10.14573/altex.2001051. View

2.
Cheng Y, He C, Wang M, Ma X, Mo F, Yang S . Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2019; 4:62. PMC: 6915746. DOI: 10.1038/s41392-019-0095-0. View

3.
Wittwehr C, Blomstedt P, Gosling J, Peltola T, Raffael B, Richarz A . Artificial Intelligence for chemical risk assessment. Comput Toxicol. 2020; 13:100114. PMC: 7043333. DOI: 10.1016/j.comtox.2019.100114. View

4.
Panagiotou G, Taboureau O . The impact of network biology in pharmacology and toxicology. SAR QSAR Environ Res. 2012; 23(3-4):221-35. DOI: 10.1080/1062936X.2012.657237. View

5.
Caporaso N . Study design and genetic susceptibility factors in the risk assessment of chemical carcinogens. Ann Ist Super Sanita. 1991; 27(4):621-30. View